Schedule 13G ownership disclosure
Flexion Therapeutics Inc
Security class unavailable · CUSIP: 33938J106
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,010,859
- Percent of class
- 7.7400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000072971-19-000119
- Form type
- SC 13G
- Filer
- Flexion Therapeutics Inc
- CIK
- CIK 1419600
- Filed
- Jan 22, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership